Explore our entire animation video library at: [ Ссылка ]
All videos from endocrine pharmacology: [ Ссылка ]

Video Summary:
GLP-1 receptor agonists are basically GLP-1 analogs resistant to degradation by DPP-4. They directly stimulate the GLP-1 receptor and cause insulin release. DPP-4 inhibitors, on the other hand, prevent the degradation of endogenous GLP-1. So the effect of GLP-1 on β cells is increased and again, more insulin is released

● More videos on Insulin and Diabetes
• Mechanism of Insulin Secretion: [ Ссылка ]
• Mechanism of Action of Sulfonylureas and Meglitinide Analogues: [ Ссылка ]
• Oral Antidiabetic Drugs Classification: [ Ссылка ]

● Follow me at:
• Facebook: [ Ссылка ]
• Instagram: [ Ссылка ]

DISCLAIMER: This video is for education purpose only. Although every effort is made to ensure accuracy of material, viewer should refer to the appropriate regulatory body/authorised websites, guidelines and other suitable sources of information as deemed relevant and applicable. In view of possibility of human error or changes in medical science, any person or organization involved in preparation of this work accepts no responsibility for any errors or omissions or results obtained from use of information in this video.

свернуть